@article{9c825b22c37b4bc3a3c1c5eed8e11385,
title = "Dynamic regulation of B cell complement signaling is integral to germinal center responses",
abstract = "Maturation of B cells within germinal centers (GCs) generates diversified B cell pools and high-affinity B cell antigen receptors (BCRs) for pathogen clearance. Increased receptor affinity is achieved by iterative cycles of T cell–dependent, affinity-based B cell positive selection and clonal expansion by mechanisms hitherto incompletely understood. Here we found that, as part of a physiologic program, GC B cells repressed expression of decay-accelerating factor (DAF/CD55) and other complement C3 convertase regulators via BCL6, but increased the expression of C5b-9 inhibitor CD59. These changes permitted C3 cleavage on GC B cell surfaces without the formation of membrane attack complex and activated C3a- and C5a-receptor signals required for positive selection. Genetic disruption of this pathway in antigen-activated B cells by conditional transgenic DAF overexpression or deletion of C3a and C5a receptors limited the activation of mechanistic target of rapamycin (mTOR) in response to BCR–CD40 signaling, causing premature GC collapse and impaired affinity maturation. These results reveal that coordinated shifts in complement regulation within the GC provide crucial signals underlying GC B cell positive selection.",
author = "Arun Cumpelik and David Heja and Yuan Hu and Gabriele Varano and Farideh Ordikhani and Roberto, {Mark P.} and Zhengxiang He and Dirk Homann and Lira, {Sergio A.} and David Dominguez-Sola and Heeger, {Peter S.}",
note = "Funding Information: The authors thank the Mount Sinai Biorepository and Pathology Core, The Mount Sinai Mouse Genetics Core (K. Kelley, director), The Mount Sinai Flow cytometry core, The Mount Sinai Microscopy Core and the Genomics Core for their technical assistance. The authors thank Y. Garcia-Carmona, L. Anderson, D. Peace and N. Samuel-Stokes (Icahn School of Medicine at Mount Sinai) for technical assistance, and C. Cunningham-Rundles (Icahn School of Medicine at Mount Sinai), R. Fairchild (Cleveland Clinic, Cleveland, OH) and F. Lin (Cleveland Clinic, Cleveland, OH) for critical comments/advice. This research was funded through the NIH (no. R01-AI141434, awarded to P.S.H. and D.D.-S., and no. R21 AI 126009, awarded to P.S.H., D.H. and S.A.L.) and NIH/NCI Cancer Center Support (grant no. P30-CA196521 to the Tisch Cancer Institute at Mount Sinai). A.C. was supported by a fellowship grant from the American Society of Transplantation, G.V. by a postdoctoral fellowship of the Lymphoma Research Foundation and M.P.R. by a Ruth L. Kirchstein National Service Award Institutional Research Training Grant (no. T32-CA078207). F.O. was supported by an Institutional Research Training Grant (no. T32-CA078207). Publisher Copyright: {\textcopyright} 2021, The Author(s), under exclusive licence to Springer Nature America, Inc.",
year = "2021",
month = jun,
doi = "10.1038/s41590-021-00926-0",
language = "English",
volume = "22",
pages = "757--768",
journal = "Nature Immunology",
issn = "1529-2908",
publisher = "Nature Publishing Group",
number = "6",
}